Definitive Assessment Of Pharmaceutical Market Still Eludes Stakeholders

BMI View: Sourcing accurate and reliable quantitative data from emerging pharmaceutical markets remains challenging. Both primary and secondary research firms are faced with sub-standard audits, language barriers, porous sales channels, a high prevalence of counterfeits, questionable national statistics, dispensing without prescriptions, sizeable 'grey markets' and widespread usage of traditional remedies.

To read the full article, please choose one of the following options: